Alberta Investment Management Corp Makes New $1.77 Million Investment in UFP Technologies, Inc. (NASDAQ:UFPT)

Alberta Investment Management Corp purchased a new stake in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 8,796 shares of the industrial products company's stock, valued at approximately $1,774,000. Alberta Investment Management Corp owned about 0.11% of UFP Technologies as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Wasatch Advisors LP grew its position in shares of UFP Technologies by 37.1% in the 4th quarter. Wasatch Advisors LP now owns 576,691 shares of the industrial products company's stock worth $141,007,000 after acquiring an additional 156,142 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in shares of UFP Technologies by 98.4% in the 1st quarter. Boston Trust Walden Corp now owns 214,147 shares of the industrial products company's stock valued at $43,196,000 after buying an additional 106,197 shares during the period. Raymond James Financial Inc. bought a new stake in shares of UFP Technologies during the 4th quarter valued at about $16,808,000. Price T Rowe Associates Inc. MD grew its holdings in shares of UFP Technologies by 55.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 178,411 shares of the industrial products company's stock valued at $43,625,000 after purchasing an additional 63,899 shares during the last quarter. Finally, Royal Bank of Canada raised its position in shares of UFP Technologies by 508.8% during the 4th quarter. Royal Bank of Canada now owns 69,145 shares of the industrial products company's stock worth $16,907,000 after purchasing an additional 57,787 shares during the period. Institutional investors and hedge funds own 87.28% of the company's stock.

Insider Activity

In related news, SVP Christopher P. Litterio sold 1,473 shares of UFP Technologies stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $220.12, for a total value of $324,236.76. Following the transaction, the senior vice president directly owned 12,585 shares in the company, valued at $2,770,210.20. The trade was a 10.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 4.40% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, Lake Street Capital set a $252.00 price objective on UFP Technologies and gave the stock a "buy" rating in a research note on Wednesday, May 7th.

UFP Technologies Price Performance

NASDAQ:UFPT traded up $14.48 during mid-day trading on Tuesday, reaching $240.75. 249,628 shares of the stock were exchanged, compared to its average volume of 88,003. The business has a fifty day moving average price of $238.69 and a 200 day moving average price of $233.07. The firm has a market capitalization of $1.86 billion, a PE ratio of 27.90 and a beta of 1.14. UFP Technologies, Inc. has a 1-year low of $178.26 and a 1-year high of $366.41. The company has a current ratio of 2.58, a quick ratio of 1.45 and a debt-to-equity ratio of 0.47.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its earnings results on Monday, August 4th. The industrial products company reported $2.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.25 by $0.25. The business had revenue of $151.18 million for the quarter, compared to analysts' expectations of $151.55 million. UFP Technologies had a return on equity of 22.19% and a net margin of 11.40%. The company's quarterly revenue was up 37.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.86 EPS.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.